iMDx

United States
Woodlawn, Ohio, United States, 37217

Company profile

iMDx company profile

iMDx is a molecular diagnostics company that develops and offers blood-based tests for oncology and transplant care. The company offers assays such as GraftAssureCore (a lab test for transplant rejection), GraftAssureIQ (a research-use kit), and DetermaIO for immunotherapy guidance. The company holds CLIA and state lab certifications.

Business identity

Contact email
[email protected]
Phone number
+1 615 255 8880
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
37217
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
8
Total equity funding
$138.3M
Last funding
Post IPO Equity / $26M / 2026-02-11
Last equity funding
Post IPO Equity / $26M
Investors
1
Lead investors
1
Founders
1
Articles
101
Exited on
2015-12-31

Founders and investors

Founders

Karen Chapman

Lead investors

Bio-Rad Laboratories

Investors

Bio-Rad Laboratories